Acies Bio

About:

Acies Bio is a biotechnology CRO offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries.

Website: https://www.aciesbio.com/

Twitter/X: AciesBio

Top Investors: EASME - EU Executive Agency for SMEs, ADM Ventures

Description:

Acies Bio is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. They provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, they offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds.

Total Funding Amount:

1.78M EUR

Headquarters Location:

Ljubljana, Ljubljana Urban Commune, Slovenia

Founded Date:

2006-01-01

Contact Email:

INFO(AT)ACIESBIO.COM

Founders:

Enej Kuscer, Štefan Fujs

Number of Employees:

51-100

Last Funding Date:

2021-10-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai